We are live on ! Find out more
CGH

Crossmark Global Holdings Portfolio holdings

AUM $7.71B
1-Year Est. Return 37.66%
This Fund
S&P 500
This Quarter Est. Return
+11.26%
1 Year Est. Return
+37.66%
3 Year Est. Return
+112.26%
5 Year Est. Return
+139.33%
10 Year Est. Return
AUM
$4.01B
AUM Growth
+$408M
Cap. Flow
+$69.4M
Cap. Flow %
1.73%
Top 10 Hldgs %
14.06%
Holding
1,291
New
51
Increased
572
Reduced
609
Closed
39

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$11.7M
2
JPM icon
JPMorgan Chase
JPM
+$11.4M
3
KMB icon
Kimberly-Clark
KMB
+$10.8M
4
CVS icon
CVS Health
CVS
+$10.5M
5
SAP icon
SAP
SAP
+$9.82M

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Financials 15.32%
3 Healthcare 13.19%
4 Consumer Discretionary 10.16%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIB icon
301
CGI
GIB
$15.5B
$2.85M 0.07%
33,137
+872
+3% +$71.9K
SAN icon
302
Banco Santander
SAN
$210B
$2.85M 0.07%
967,192
-59,966
-6% -$164K
JBL icon
303
Jabil
JBL
$35.8B
$2.85M 0.07%
41,756
-194
-0.5% -$12.8K
VSXY
304
Victoria's Secret
VSXY
$7.83B
$2.84M 0.07%
79,418
-218
-0.3% -$8.66K
CARR icon
305
Carrier Global
CARR
$52.8B
$2.83M 0.07%
68,520
+2,344
+4% +$95.1K
OC icon
306
Owens Corning
OC
$12.4B
$2.82M 0.07%
33,066
-649
-2% -$56.9K
AWK icon
307
American Water Works
AWK
$26.9B
$2.8M 0.07%
18,374
+841
+5% +$121K
MRNA icon
308
Moderna
MRNA
$23.6B
$2.78M 0.07%
15,484
+707
+5% +$116K
QGEN icon
309
Qiagen
QGEN
$8.72B
$2.77M 0.07%
52,423
+5,455
+12% +$269K
IT icon
310
Gartner
IT
$11.7B
$2.76M 0.07%
8,219
+745
+10% +$240K
VRTX icon
311
Vertex Pharmaceuticals
VRTX
$126B
$2.75M 0.07%
9,537
+410
+4% +$125K
FMX icon
312
Fomento Económico Mexicano
FMX
$41.7B
$2.75M 0.07%
35,226
+918
+3% +$67.5K
HMC icon
313
Honda
HMC
$41.3B
$2.73M 0.07%
119,593
-8,683
-7% -$201K
ALL icon
314
Allstate
ALL
$67.5B
$2.72M 0.07%
20,042
-5,758
-22% -$753K
JKHY icon
315
Jack Henry & Associates
JKHY
$11.1B
$2.71M 0.07%
15,448
+2,144
+16% +$396K
BN icon
316
Brookfield
BN
$108B
$2.71M 0.07%
129,203
+26,019
+25% +$583K
MSI icon
317
Motorola Solutions
MSI
$77.4B
$2.71M 0.07%
10,504
+1,533
+17% +$383K
NVS icon
318
Novartis
NVS
$297B
$2.69M 0.07%
29,612
-111
-0.4% -$9.35K
AMX icon
319
America Movil
AMX
$71.2B
$2.67M 0.07%
146,692
-8,478
-5% -$157K
NEM icon
320
Newmont
NEM
$119B
$2.66M 0.07%
56,325
+684
+1% +$30.5K
RSG icon
321
Republic Services
RSG
$66B
$2.65M 0.07%
20,510
-271
-1% -$36.2K
CRUS icon
322
Cirrus Logic
CRUS
$6.26B
$2.64M 0.07%
35,453
+6,703
+23% +$482K
NVO
323
Novo Nordisk
NVO
$209B
$2.64M 0.07%
39,028
-354
-0.9% -$20.8K
NDAQ icon
324
Nasdaq
NDAQ
$52.9B
$2.62M 0.07%
42,656
+19,103
+81% +$1.19M
MOH icon
325
Molina Healthcare
MOH
$10.3B
$2.6M 0.06%
7,884
+1,163
+17% +$395K

Similar funds

Crossmark Global Holdings's Q4 2022 Portfolio in Review

As of Q4 2022, Crossmark Global Holdings held 1,291 positions worth $4.01B, up 11% from $3.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Crossmark Global Holdings's Q4 2022 filing shows 51 new, 572 increased, 609 reduced and 39 closed positions. Its largest new stake was Berry Global Group, Inc.: 28,856 shares worth $1.6M. The largest sale was Intel, an estimated $11.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • Crossmark Global Holdings's largest Q4 2022 buy was Berry Global Group, Inc.: 28,856 shares worth $1.6M.
  • Crossmark Global Holdings added most to Accenture in Q4 2022, an estimated $11.5M increase.
  • Crossmark Global Holdings's biggest Q4 2022 reduction was Intel, cutting an estimated $11.7M.
  • Crossmark Global Holdings fully exited CEMIG Preferred Shares in Q4 2022, selling an estimated $7.14M.
  • Crossmark Global Holdings's ten largest holdings make up 14% of its $4.01B portfolio in Q4 2022.
  • Crossmark Global Holdings opened 51 new positions and closed 39 in Q4 2022.
  • Crossmark Global Holdings's portfolio value rose 11% quarter-over-quarter to $4.01B.

Based on Crossmark Global Holdings's 13F filing for Q4 2022, filed 19 Jan 2023.